-+ 0.00%
-+ 0.00%
-+ 0.00%

JW Therapeutics Agrees to HKD 160 Million Private Share Placement

PUBT·11/15/2026 12:02:04
JW Therapeutics Agrees to HKD 160 Million Private Share Placement
  • JW Cayman Therapeutics agreed on November 15, 2026, to raise HK$ 160 million through a share subscription by two institutional investors.
  • The placement comprises 61,185,465 new shares at HK$ 2.615 each, a 2.97% discount to the last closing price.
  • China Hongqiao Holdings will subscribe for 38,240,915 shares; Novo Vista Limited Partnership will purchase 22,944,550 shares.
  • The new shares will represent approximately 12.8% of enlarged share capital, subject to completion conditions.
  • Estimated net proceeds of HK$ 158.8 million will primarily fund CAR-T research, technology platforms and manufacturing capabilities.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261115-12413089), on November 15, 2026, and is solely responsible for the information contained therein.